NEW YORK, May 06, 2019 (GLOBE NEWSWIRE) -- Ryah Medtech Inc., today announced that Michael Hart has joined the company as Vice-President, Business Development.

Focused on the global medical cannabis market, RYAH is a data aggregation and technology company that markets RYAH, the groundbreaking dose-measuring medicinal vaporizer used by patients for cannabinoids or dry herbs.

Far from being an outsider to cutting-edge companies in burgeoning industries, Mr. Hart comes to Ryah following a number of commercial mandates where he was instrumental to business growth through highly-successful consultative selling and joint venture development, i.e., not just racking up impressive sales figures but also bringing in numerous international corporations, both as customers and as partners.

Mr. Hart’s key mission will be to focus on opening the European and South American markets for Ryah, where the appreciation of medicinal cannabis is gaining rapid recognition and acceptance. He will be working out of London.

“Ryah has made incredible headway in the medical cannabis market in the course of the last year, launching its products in several States in the US and taking steps to gain accreditation with Health Canada, to name but a few milestones,” declared Mr. Hart. “It would be an understatement to say that it’s exciting to be joining the Ryah family at a time where medicinal cannabis is gaining worldwide attention and acceptance”, he went on to say.

Ryah’s newly appointed President and CEO, Gregory Wagner, had this to say about Mr. Hart’s nomination: “A highly-experienced business development executive with an impressive track record, Michael comes to us with a wealth of knowledge and quite an array of successes under his belt. He speaks several languages, shows excellent interpersonal skills and has vast marketing, business development, and consultative sales experience. He is also well-versed in financial forecasting and business planning and knows how to reach set targets”.

The RYAH vaporizer is a precision medicinal device that captures the amount of vapor a patient inhales. It creates a consistent and reliable vaporizing experience for patients by providing them with unprecedented temperature and dose control. The one-of-a-kind inhaler uses high-tech disposable medicinal cartridges that have embedded QR codes which serve to identify the cartridge’s contents, and comes accompanied with a highly popular mobile application.

The RYAH system provides users with the ability to track which cartridges work best for their specific needs and collects data for all parties who are in one way or another involved in the process, from the growers to pharmacies, laboratories and pharma companies. The data is integrated into a leading-edge big data AI platform that identifies correlations between cannabinoids and medical indications.